Staff report on Sanofi's strategic use of third parties to influence the FDA [[electronic resource] /] / prepared by the staff of the Committee on Finance, United States Senate

• Pubblicazione: Washington : , : U.S. G.P.O., , 2011
• Descrizione fisica: 1 online resource (iii, 177 pages)
• Soggetto topico: Drug approval - Corrupt practices - United States; Anticoagulants (Medicine) - Government policy - United States; Generic drugs - Government policy - United States
• Note generali: Title from title screen (viewed on July 21, 2011).; At head of title: 112th Congress, 1st session. Committee print.; Paper version available for sale by the Supt. of Docs., U.S. G.P.O.; "May 2011."
• Nota di bibliografia: Includes bibliographical references.
• Titolo autorizzato: Staff report on Sanofi's strategic use of third parties to influence the FDA
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910700723503321
• Lo trovi qui: Univ. Federico II